The ankle-brachial index (ABI) is an easy-to-use, non-invasive and reliable diagnostic tool for assessing peripheral arterial occlusive disease (PAOD). The CHADS2 (congestive heart failure, hypertension, age ≧75 years, diabetes, prior stroke) score is a simple and popular clinical parameter that is used to assess the risk of stroke in patients with atrial fibrillation (AF). Because all five components of the CHADS2 score are risk factors for PAOD, the score should have a strong correlation with the presence of PAOD. However, there are limited studies regarding the association between the CHADS2 score and PAOD in patients without AF. Therefore, the aim of the present study was to investigate whether the CHADS2 score is positively associated with PAOD in patients without AF. Methods: A total of 1,320 patients without AF were included in this study. The ABI was measured using an ABI-form device. PAOD was defined as an ABI of ＜0.9 in either leg. Results: Among the 1,320 subjects (mean age: 60.3±13.4 years), the prevalence of an ABI of ＜0.9 was 5.7%. A multivariate analysis showed that an increased age (odds ratio [OR], 1.054; p＜0.001), decreased estimated glomerular filtration rate (OR, 0.971; p＜0.001) and increased CHADS2 score (OR, 1.861; p＜0.001) were independently associated with an ABI of ＜0.9. Conclusions: Our study demonstrated that the CHADS2 score is significantly associated with an ABI of ＜0.9 in non-AF patients. Further prospective studies are needed to examine the ability of the CHADS2 score to predict the incidence of PAOD. J Atheroscler Thromb, 2013; 20:000-000.
Introduction
Theankle-brachialindex(ABI)isaneasy-to-use, non-invasiveandreliablediagnostictoolforassessing peripheral arterial occlusive disease (PAOD) [1] [2] . An ABIof＜0.9hasbeenestablishedtobeareliablediag-nosticmarkerforPAOD [1] [2] andastrongpredictorof Address for correspondence: Ho-Ming Su, Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, 482, Shan-Ming Rd.,Hsiao-KangDist.,812Kaohsiung,Taiwan,R.O.C. E-mail:cobeshm@seed.net.tw Received:August23,2013 Acceptedforpublication:October21,2013 overallandcardiovascularmortality [3] [4] [5] . PAOD is a systemic atherosclerotic process for whichthemajorriskfactorsaresimilartoatherosclerosisinthecoronaryandcarotidarteries 6) .Majorrisk factors for PAOD include an advanced age, cigarette smoking, diabetes mellitus, dyslipidemia and hypertension [6] [7] . In addition, chronic kidney disease, race, obesity, elevated inflammatory markers, stroke and congestiveheartfailurehavealsobeenreportedtobe associatedwithPAOD [6] [7] [8] [9] [10] [11] [12] . The CHADS2 (congestive heart failure, hypertension,age≧75years,diabetes,priorstroke)scoreis a reliable, simple and popular clinical score that is usedtoassesstheriskofstrokeinpatientswithatrial surementwasperformedonceineachpatient.
Calculation of the CHADS2 Score
The CHADS2 score was calculated for each patient based on a point system in which 2 points wereassignedforahistoryofstrokeand1pointwas assigned for an age ≧75 years and the presence of congestive heart failure, hypertension or diabetes. Congestiveheartfailurewasdefinedaccordingtothe Framingham criteria. Hypertension was defined as a systolic blood pressure of ≧140 mmHg, a diastolic blood pressure of ≧90 mmHg or the use of antihypertensive drugs. Diabetes was defined as a fasting bloodglucoselevelgreaterthan126mg/dLortheuse of hypoglycemic agents to control the blood glucose level.Ahistoryofpriorstrokewasdefinedasahistory ofacerebrovascularaccident,includingcerebralbleedingorinfarction.
Collection of Demographic, Medical and Laboratory Data
Demographic and medical data, including age, gender, smoking history (ever versus never) and comorbid conditions, were obtained from medical recordsorinterviewswiththepatients.Thebodymass index(BMI)wascalculatedastheratiooftheweight in kilograms divided by the square of the height in meters.Thelaboratorydatawereobtainedfromfastingbloodsamplesusinganautoanalyzer(RocheDiagnosticsGmbH,D-68298MannheimCOBASIntegra 400).Theestimatedglomerularfiltrationrate(eGFR) was calculated using the four-variable equation provided in the Modification of Diet in Renal Disease (MDRD)study 20) .Inaddition,informationregarding patient medications, including aspirin, angiotensinconvertingenzymeinhibitors(ACEIs),angiotensinⅡ receptor blockers (ARBs),β-blockers, calcium channel blockers, diuretics and statins, during the study period was obtained from the patients' medical records.
Statistical Analysis
The SPSS 15.0 (SPSS, Inc., Chicago, Illinois, USA) software package was used for the statistical analysis.Thedataareexpressedaspercentagesorthe mean±standard deviation. Continuous and categoricalvariableswerecomparedbetweengroupsusingthe independent samples t-test and Chi-square test, respectively. The relationships between two continuousvariableswereassessedusingabivariatecorrelation method(Pearson'scorrelation).Subsequently,variables found to be significantly correlated in the univariate analysiswerefurtheranalyzedusingaforwardmultifibrillation(AF) [13] [14] .PatientswithAFhaveanaverage annualriskofstrokeofapproximately5% 13, 15) .There is a direct relationship between the CHADS2 score and the annual risk of stroke in AF patients treated without aspirin or warfarin therapy 14) . In addition, recentresearchhasextendedtheuseoftheCHADS2 score to non-AF populations [16] [17] . Welles et al. reportedthatthescorecanbeusedtopredictischemic stroke/transientischemicaccidentsinnon-AFsubjects withcoronaryheartdisease 16) .Pociet al.alsoshowed that,inpatientswithacutecoronarysyndromewithout AF, the score is significantly associated with allcause mortality 17) . Because congestive heart failure, hypertension, an old age, diabetes and stroke are all riskfactorsforPAOD [6] [7] [8] [9] [10] [11] [12] ,theCHADS2scoreshould haveastrongcorrelationwiththeincidenceofPAOD. However,therearelimitedstudiesregardingtheassociation between the CHADS2 score and PAOD in non-AF patients. Therefore, the aim of the present studywastoinvestigatewhethertheCHADS2scoreis positivelyassociatedwithPAOD.
Methods

Study Subjects
Thiswasacross-sectionalstudy.Thestudysubjects were prospectively and consecutively recruited fromagroupofpatientswhoarrangedforechocardiographicexaminationsatKaohsiungMunicipalHsiaoKang Hospital. Patients with significant aortic or mitralvalvedisease,AF,significantankleedemaand/ orinadequateimagevisualizationwereexcluded.Ultimately, a total of 1,320 patients (mean age: 61.1± 13.7years,743men/577women)wereincluded.The study protocol was approved by the institutional reviewboardofKaohsiungMedicalUniversityHospital(KMUH-IRB).Informedconsentwasobtainedin writingfromallpatients,andtheclinicalinvestigation was conducted according to the principles expressed intheDeclarationofHelsinki.Thepatientsprovided theirinformedconsentforpublicationoftheirclinical details.
Assessment of ABI
ThevaluesofABIweremeasuredusinganABIform device (VP1000; Colin Co. Ltd., Komaki, Japan),whichautomaticallyandsimultaneouslymeasured the blood pressure in both arms and ankles according to an oscillometric method [18] [19] . The ABI wascalculatedastheratiooftheanklesystolicblood pressure to the higher systolic blood pressure of the arms. After obtaining bilateral ABI values, the lower value was used for the later analyses. The ABI mea- Because a high value of ABI (ABI ≧1.3) is relatedtopoorarterialcompressibilityresulting from stiffness and calcification, we performed a subgroup analysis of the 1,296 patients with an ABI of ＜1.3 and found similar results, i.e. an increased age, low eGFR, diuretic use and high CHADS2 score (OR, 1.818;95%CI,1.384-2.388;p＜0.001)wereassociatedwithanABIof＜0.9.
In addition, Fig. 1A shows the percentage of patients with an ABI of ＜0.9 with respect to the CHADS2 score. The percentage of patients with an ABIof＜0.9amongthosewithaCHADS2scoreof0, 1, 2, 3, 4 and 5 was 0.7%, 1.7%, 7.5%, 20.4%, 21.1% and 42.9%, respectively (p＜0.001). There were no patients with a CHADS2 score of 6 in our study. Fig. 1B shows the percentage of patients with anABIof ＜0.9 amongthosewithaCHADS2score plelogisticregressionanalysistoidentifyfactorsassociatedwithanABIof ＜0.9.Alltestsweretwo-sided, and the level of significance was established as p＜ 0.05.
Results
The mean age of the 1,320 patients was 60.3± 13.4 years. The prevalence of an ABI of ＜0.9 was 5.7%. 
Discussion
Inthepresentstudy,weevaluatedtheassociation between an ABI of ＜0.9 and the CHADS2 score in non-AF patients. We found that an ABI of ＜0.9 is of ＜2 and ≧2. The percentage of patients with an ABI of ＜0.9 among those with a CHADS2 score of ＜2 and ≧2 was 1.4% and 12.2%, respectively (p＜ 0.001). 
Thevaluesareexpressedasoddsratios(ORs)and95%confidenceintervals(CIs).TheabbreviationsarethesameasinTable1.
Advance Publication
afterexcludingsubjectswithabnormallyhighABIvalues(ABI≧1.3)andfoundsimilarresults.
A CHADS2 score of ≧2 is a well-known risk factorforstrokeinAFpatients.Gallegoet al.reported that an abnormal ABI is associated with a CHADS2 score of ≧2 in AF patients 11) . The present study of non-AF patients similarly found that patients with a CHADS2 score of ≧2 had a higher incidence of an ABIof＜0.9thanthosewithaCHADS2scoreof＜2. ThisfindingsuggeststhatahigherCHADS2scoreis useful for identifying subjects with PAOD among non-AFpatients.
Patients with chronic kidney disease have a higherriskandincidenceofformsofgeneralizedatherosclerosis, such as coronary artery disease and PAOD, in the literature 7, [28] [29] . Selvin et al. also reportedthatanimpairedkidneyfunctionispositively associatedwithprevalentPAOD 7) .Ourresultsconsistently demonstrated that a low eGFR is an independentriskfactorforanABIof＜0.9.
There are several limitations to our study. First, because our study was a cross-sectional study, we couldonlyconfirmthepresenceofasignificantassociationbetweentheCHADS2scoreandanABIof ＜ 0.9;wewereunabletoelucidatethetruecause-effect relationshipbetweenthesetwovariables.Second,the majorityofourpatientswerechronicallytreatedwith antihypertensive medications. For ethical reasons, we didnotwithdrawthesemedicationsandaretherefore unable to exclude the influence of antihypertensive agentsonourfindings.However,weadjustedforthese parameters in the multivariate analysis. Third, since thesubjectswerealreadybeingevaluatedforheartdisease,thestudywassusceptibletoselectionbias,makingthefindingspotentiallylessgeneralizable.
In conclusion, our study demonstrated that the CHADS2scoreissignificantlyassociatedwithanABI of ＜0.9 in non-AF patients. Calculating the CHADS2scoremayhelptoidentifyhigh-risknon-AF patients with PAOD. Further prospective studies are needed to examine the ability of the CHADS2 score topredicttheincidenceofPAOD.
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independentlyassociatedwiththeCHADS2score.In addition, an advanced age and low eGFR were also foundtobesignificantlycorrelatedwithanABIof ＜ 0.9.
PAOD is a systemic atherosclerotic process 21) . RiskfactorsforPAODincludeanadvancedage,diabetes,hypertension,stroke,heartfailureandsoon [6] [7] [8] [9] [10] [11] [12] . The prevalence of PAOD is associated with an advanced age in the literature 7, [22] [23] . Selvin et al. reported that the prevalence of PAOD is 4.3% in adults40yearsofageoroldercomparedwith14.5% inthose70yearsofageorolder 7) .Patientswithdiabetes have a 1.5-to 4-fold increased risk of developing PAOD [23] [24] [25] . Hypertension has been reported to exhibit a strong association with PAOD 7, 23, 26) . The Framingham study also showed a 2.5-to 4-fold increaseintheriskofdevelopingintermittentclaudication among patients with hypertension 23) . Because PAOD and stroke are both vascular-related diseases and share similar risk factors, there is also a strong association between PAOD and stroke [8] [9] [10] . In addition,anabnormalABIhasbeenreportedtobeassociated with heart failure in patients with nonvalvular AF 11) . Moreover, Adesunloye et al. showed that patients with congestive heart failure are over three times more likely to have PAOD compared to the general population and that functional limitations in patients with congestive heart failure are associated with PAOD after adjusting for potential confounders 12) . TheCHADS2scoreisavalidatedclinicalpredic-tiontoolthatiscommonlyusedtoestimatetheriskof strokeinAFpatients.Thescoreiswidelyusedinclinical practice to guide decisions regarding antiplatelet and anticoagulation therapy due to its simplicity of calculation [13] [14] . Because the five components of the CHADS2 score are all significantly correlated with PAOD, the score should have a strong correlation with PAOD. In the present study, we consistently demonstrated that all five components of CHADS2 sore and the CHADS2 sore itself are associated with anABIof＜0.9intheunivariateanalyses.Inthemultivariate analysis, the CHADS2 score remained a major determinant of an ABI of ＜0.9. Hence, the CHADS2scoremayhelptoidentifyhigh-riskpatients withPAOD.
AnABIof≧1.3isconsideredtoindicatemedial arterycalcification 27) ,whichisrelatedtopoorarterial compressibility resulting from stiffness and calcification.AlthoughbothPAODandmedialarterycalcification are components of peripheral arterial disease, thepathogenesisofthetwoconditionsisnotsimilar. In our study, we also performed a subgroup analysis Advance Publication Journal of Atherosclerosis and Thrombosis Accepted for publication: October 21, 2013 Published online: November 27, 2013 
